ストックスクリーナーアプリを入手
1.23
0.82%
0.01
アフターアワーズ：
1.19
-0.04
-3.25%
前日終値:
$1.22
開ける：
$1.22
24時間の取引高:
107.89K
Relative Volume:
0.74
時価総額：
$4.82M
収益：
$17.72M
当期純損益:
$-3.37M
株価収益率:
-0.6035
EPS:
-2.038
ネットキャッシュフロー:
$-3.72M
1週間 パフォーマンス:
+18.27%
1か月 パフォーマンス:
-48.10%
6か月 パフォーマンス:
-67.29%
1年 パフォーマンス:
-64.14%
1日の値動き範囲:
$1.19
$1.25
1週間の範囲:
$1.02
$1.25
52週間の値動き範囲:
$0.8501
$6.9199
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
名前
Sonoma Pharmaceuticals Inc
セクター
電話
800-759-9305
住所
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA vs TAK, ZTS, TEVA, HLN, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
1.23 | 4.78M | 17.72M | -3.37M | -3.72M | -2.038 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
Sonoma Pharmaceuticals Inc (SNOA) 最新ニュース
Sonoma Pharmaceuticals (SNOA) outlines plan to reincorporate from Delaware to Nevada - Stock Titan
Sonoma Pharmaceuticals Completes Equity Offering to Raise Capital - The Globe and Mail
Sonoma Pharmaceuticals (NASDAQ: SNOA) closes $4M stock and warrant sale - Stock Titan
SNOA Sonoma Pharmaceuticals reports narrow Q1 2026 EPS miss as shares rise 1.92 percent on mild positive investor sentiment.Cost Advantage - Newser
SNOA Director Jacoby Vanessa Stock Option Filing, April 28, 2026 - Meyka
Sonoma Pharmaceuticals registers HOCl facial spray under U.S. cosmetics law - MSN
What's Going On With Sonoma Pharma Stock Monday? - Benzinga
2.96M-unit offering priced at $1.35 — Sonoma Pharmaceuticals (NASDAQ: SNOA) - Stock Titan
SNOA Drops As Sonoma Pharmaceuticals Launches Dilutive Offering - StocksToTrade
Sonoma Pharmaceuticals (SNOA) Secures $4M in Public Offering - GuruFocus
Sonoma Pharmaceuticals prices $4M stock offering at $1.35 per share - Investing.com
Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering - ACCESS Newswire
[EFFECT] Sonoma Pharmaceuticals, Inc. SEC Filing - Stock Titan
Sonoma Pharmaceuticals (NASDAQ: SNOA) files S-1 for $5M unit and warrant sale - Stock Titan
SNOA (Sonoma Pharmaceuticals Inc.) Q1 2026 revenue growth drives 2.75 percent share gain despite narrow EPS miss.ROE - UBND thành phố Hải Phòng
According to the latest filing from the U.S. Securities and Exchange Commission (SEC), Sonoma Pharmaceuticals, Inc. announced the launch of a public offering, aiming to raise a total of $5 million through the issuance of units. - Exchange Bitget
Sonoma Pharmaceuticals IncOffers Units In Public Offering For Gross Proceeds Of $5 MillionSEC Filing - TradingView
Sonoma Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933 - Moomoo
Sonoma Pharmaceuticals (NASDAQ: SNOA) plans $5M stock and warrant sale - Stock Titan
Will Sonoma Pharmaceuticals Inc stock go up in YEARQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
US Stocks Recap: Can Sonoma Pharmaceuticals Inc expand into new marketsWeekly Trade Report & Safe Capital Growth Tips - baoquankhu1.vn
3 Biotech Stocks Surge with Momentum - National Today
Sonoma Pharmaceuticals and Kenvue Brands Sign Manufacturing and Supply Agreement for Microcyn® Technology Products Through 2027 - Minichart
Sonoma Pharmaceuticals enters manufacturing agreement with Kenvue Brands - Investing.com
Sonoma Pharmaceuticals Enters U.S. Manufacturing and Supply Pact With Kenvue for Microcyn Line - TradingView — Track All Markets
Sonoma Pharmaceuticals (SNOA) signs Kenvue U.S. Microcyn manufacturing and supply deal - Stock Titan
Sonoma Pharmaceuticals, Inc. Enters Manufacturing And Supply Agreement With Kenvue Brands LLC - marketscreener.com
Breakout Move: Is Sonoma Pharmaceuticals Inc currently under institutional pressure2026 Intraday Action & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Is Sonoma Pharmaceuticals (SNOA) Stock Worth Holding | Price at $2.33, Down 1.90%Bollinger Bands - Newser
Aug Opening: How correlated is Sonoma Pharmaceuticals Inc to the S P5002026 Breakouts & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin - The Patriot Ledger
Sonoma Pharmaceuticals (SNOA) jumps 16% after hours on burn relief hydrogel launch in Walmart, CVS - msn.com
Sonoma Pharmaceuticals (SNOA) Jumps 16% After Hours On Burn Relief Hydrogel Launch In Walmart, CVS - Benzinga
Market Wrap: How correlated is Sonoma Pharmaceuticals Inc to the S P5002026 Sector Review & Fast Moving Trade Plans - baoquankhu1.vn
Published on: 2026-03-26 16:02:54 - baoquankhu1.vn
Sonoma Pharmaceuticals Launches Advanced Burn Relief Hydrogel in Walmart and CVS Stores Nationwide - AD HOC NEWS
CVS Now Stocking Sonoma Pharmaceuticals' HOCl-Based Burn Relief Hydrogel - gurufocus.com
Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart - Bitget
Sonoma Pharmaceuticals launches burn relief gel at CVS, Walmart - Investing.com
Sonoma Pharmaceuticals launches burn relief gel at CVS, Walmart By Investing.com - Investing.com UK
Pharma News: What is Sonoma Pharmaceuticals Incs revenue forecastQuarterly Risk Review & Real-Time Stock Price Movement Reports - baoquankhu1.vn
SNOA Technical Analysis & Stock Price Forecast - Intellectia AI
Sonoma Pharmaceuticals launches Aquanil AD product line By Investing.com - Investing.com South Africa
Sonoma Pharmaceuticals Inc (SNOA) 財務データ
収益
当期純利益
現金流量
EPS
0.67%
2.13%
大文字化:
|
ボリューム (24 時間):